The goal of the New.Tech development platform is to develop a novel technology that combines droplet microarrays for miniaturized, parallel high-throughput chemical synthesis and drug screening with a light-induced liquid manipulation method in droplets based on FLUCS technology. This combination enables miniaturized high-throughput combination syntheses as well as miniaturized biochemical and cell-based screenings with extended possibilities, such as cell manipulation in droplets, mixing in droplets and light-induced fusion of droplets. Such a new technology combining light-induced nanoliter droplet manipulation with ultra-high throughput and miniaturization can be integrated into various other self-driving platforms of this application. In parallel to the expansion of the Self-Driving Labs, we also want to drive forward technology development at the highest level and specifically establish a technology research and development platform in which the technologies and methods developed at KIT are to be refined and adapted to use cases to such an extent that unique research instruments infrastructure and novel workflows are created for disruptive mature technologies that enable miniaturized and parallelized and contactless precision assays in health and life science technologies. Novel light-controlled robotics in combination with AI and digital innovations on the micrometer to millimeter scale can thus expand the resolution of what is possible in life science technologies